0
     

Report Added
Report already added
Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027

The companion animal diagnostics market is projected to reach USD 3.8 Billion by 2027 from USD 2.4 Billion in 2022 at a CAGR of 9.6% during the forecast period. The growth in this market is mainly attributed to the increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.

“Clinical Biochemistry segment holds largest share in the companion animal diagnostics market in 2021”

The companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies on the basis of technologies. The clinical biochemistry segment holds the largest share of the companion animal diagnostics market in 2021. Clinical biochemistry is an important technology used for screening infectious and metabolic disorders in small animals. The clinical biochemistry market is segmented into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis.

“Clinical Pathology segment is expected to grow at the fastest growth rate during 2022-2027”

The companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications based on application type. In 2021, clinical pathology was the largest application segment in this market owing to the high volume of clinical pathology tests performed on companion animals. Clinical pathology encompasses hematology, clinical chemistry, cytopathology, endocrinology, urinalysis, coagulation, immunohematology, and general pathology. In the case of chronic diseases, veterinarians recommend routine blood and urine check-ups, wherein pathologists work alongside vets in order to evaluate the true causes of diseases.

“The diagnostics laboratories holds the largest share of companion animal diagnostics market in 2021”

The companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals & clinics, research institutes & universities,and home care settings based on the end user type. The diagnostic laboratories segment holds the largest share of of this market in 2021. The large share of this segment can be attributed to a large number of samples received for analysis in these laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.

“North America accounted for the largest share of the companion animal diagnostics market in 2021”

The companion animal diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa based on the region type. North America holds largest share of of the companion animal diagnostics market in 2021. The large share of this segment can be attributed to the increasing animal population, growing pet insurance, and rising animal health expenditure in North America. The Asia Pacific region is projected to grow at a CAGR of during the forecast period. Factors such as the rapidly increasing animal population, growing awareness about animal welfare, and the rising prevalence of zoonotic diseases are driving the growth of this regional market.

A breakdown of the primary participants (supply-side) for the companion animal diagnostics market referred to for this report is provided below:

•By Company Type: Tier 1–60%, Tier 2–30%, and Tier 3–10%
•By Designation: C-level–30%, Director Level–50%, and Others–20%
•By Region: North America–45%, Europe–15%, Asia Pacific–23%, Latin America- 10%, and Middle East and Africa– 5%
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Some major players in this market are Idexx Laboratories, INC. (US), Zoetis, INC. (US), Heska Corporation (US), Thermo Fisher Scientific, INC. (US), Biomérieux SA (France), Virbac (France), Neogen Corporation (US), Fujifilm Holdings Corporation (Japan), Indical Bioscience GmbH (Germany), Idvet (France), Randox Laboratories, LTD. (UK), Shenzhen Mindray Animal Medical Technology Co., Ltd. (China), and BioNote, Inc (South Korea).

Research Coverage:
The market study covers the companion animal diagnostics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by Technology, Application, Animal, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the companion animal diagnostics market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Table of Contents

1INTRODUCTION49
1.1STUDY OBJECTIVES49
1.2MARKET DEFINITION49
1.3STUDY SCOPE51
1.3.1MARKETS COVERED – BY TYPE51
1.3.2MARKETS COVERED – BY REGION52
1.3.3YEARS CONSIDERED52
1.4CURRENCY53
TABLE 1STANDARD CURRENCY CONVERSION RATES53
1.5LIMITATIONS53
1.6STAKEHOLDERS53
1.7SUMMARY OF CHANGES54
2RESEARCH METHODOLOGY55
2.1RESEARCH DATA55
FIGURE 1RESEARCH DESIGN55
2.1.1SECONDARY DATA55
2.1.1.1Key data from secondary sources57
2.1.2PRIMARY DATA57
FIGURE 2PRIMARY SOURCES57
2.1.2.1Key data from primary sources58
2.1.2.2Key industry insights59
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS59
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION60
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION60
2.2MARKET SIZE ESTIMATION61
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.62
FIGURE 7SUPPLY SIDE ANALYSIS OF TOP COMPANIES (2021)62
FIGURE 8CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2022–2027)64
FIGURE 9TOP-DOWN APPROACH64
2.3MARKET BREAKDOWN & DATA TRIANGULATION66
FIGURE 10MARKET DATA TRIANGULATION METHODOLOGY66
2.4MARKET SHARE ESTIMATION66
2.5RESEARCH ASSUMPTIONS67
2.6RISK ASSESSMENT67
TABLE 2RISK ASSESSMENT: COMPANION ANIMAL DIAGNOSTICS MARKET67
3EXECUTIVE SUMMARY68
FIGURE 11COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION)68
FIGURE 12COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)69
FIGURE 13COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2022 VS. 2027 (USD MILLION)70
FIGURE 14COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)71
FIGURE 15GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET72
4PREMIUM INSIGHTS73
4.1COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW73
FIGURE 16GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH73
4.2REGIONAL MIX: COMPANION ANIMAL DIAGNOSTICS MARKET74
FIGURE 17ASIA PACIFIC TO REGISTER CAGR OF 10.1% DURING FORECAST PERIOD74
4.3ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY AND COUNTRY (2021)75
FIGURE 18CHINA TO HOLD LARGEST SHARE OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET IN 202175
4.4COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES76
FIGURE 19AUSTRALIA AND MEXICO TO GROW AT HIGHEST RATE DURING FORECAST PERIOD76
4.5COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS77
FIGURE 20DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE77
5MARKET OVERVIEW78
5.1INTRODUCTION78
5.2MARKET DYNAMICS78
FIGURE 21COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES79
5.2.1DRIVERS79
5.2.1.1Increasing companion animal population79
TABLE 3PET POPULATION, BY ANIMAL, 2014–2020 (MILLION)80
5.2.1.2Rising demand for pet insurance and growing animal health expenditure80
TABLE 4AVERAGE PREMIUMS PAID IN US, 2019 VS. 202081
FIGURE 22US: PET INDUSTRY EXPENDITURE, 2010–202081
TABLE 5NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION)82
5.2.1.3Growing number of veterinary practitioners and their rising income levels in developed countries82
TABLE 6NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–201883
5.2.2RESTRAINTS83
5.2.2.1Rising pet care costs83
5.2.3OPPORTUNITIES84
5.2.3.1Increased use of PCR testing panels to rule out COVID-19 virus in animals84
5.2.3.2Growing demand for rapid tests and portable instruments for point-of-care diagnostic services84
5.2.3.3Use of advanced technologies to improve disease diagnosis accuracy in companion animals84
5.2.4CHALLENGES85
5.2.4.1Shortage of veterinary practitioners in developing countries85
TABLE 7NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 201885
5.3INDUSTRY TRENDS86
5.3.1ADOPTION OF MULTIPLE TESTING PANELS86
TABLE 8MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS86
5.3.2OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES86
5.3.3GROWING CONSOLIDATION IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY86
TABLE 9MAJOR ACQUISITIONS IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY87
5.4DISEASE TRENDS87
5.4.1ZOONOTIC DISEASES87
TABLE 10COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS GLOBALLY88
5.4.2OBESITY AND DIABETES89
5.5TECHNOLOGICAL ANALYSIS89
5.5.1KEY TECHNOLOGY89
5.5.1.1Development of portable instruments for POC diagnostic services89
TABLE 11PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS89
5.5.2ADJACENT TECHNOLOGY89
5.5.2.1Development of rapid and sensitive veterinary diagnostic kits89
5.6PRICING ANALYSIS90
TABLE 12REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD)90
5.7IMPACT OF COVID-19 ON COMPANION ANIMAL DIAGNOSTICS MARKET91
TABLE 13GLOBAL SNAPSHOT OF REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS91
FIGURE 23MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 202092
5.8TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN COMPANION ANIMAL DIAGNOSTICS MARKET93
FIGURE 24YC–YCC SHIFT IN COMPANION ANIMAL DIAGNOSTICS MARKET93
5.9VALUE CHAIN ANALYSIS93
FIGURE 25COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS94
5.10ECOSYSTEM MARKET MAP94
FIGURE 26COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS95
FIGURE 27COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP96
5.11PORTER’S FIVE FORCES ANALYSIS97
TABLE 14COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS97
5.11.1THREAT OF NEW ENTRANTS97
5.11.2THREAT OF SUBSTITUTES98
5.11.3BARGAINING POWER OF SUPPLIERS98
5.11.4BARGAINING POWER OF BUYERS98
5.11.5INTENSITY OF COMPETITIVE RIVALRY98
5.12SUPPLY CHAIN ANALYSIS99
FIGURE 28COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS100
5.13REGULATORY ANALYSIS100
5.13.1US100
5.13.2EUROPE101
5.14PATENT ANALYSIS102
5.14.1PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS102
FIGURE 29PATENT PUBLICATION TRENDS (2011–APRIL 2022)102
5.14.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS103
FIGURE 30TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2011–APRIL 2022)103
FIGURE 31TOP APPLICANT COUNTRIES/REGIONS FOR COMPANION ANIMAL DIAGNOSTICS PATENTS (JANUARY 2011–APRIL 2022)104
5.15KEY CONFERENCES & EVENTS DURING 2021-2023104
TABLE 15COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS104
5.16KEY STAKEHOLDERS & BUYING CRITERIA105
5.16.1KEY STAKEHOLDERS IN BUYING PROCESS105
FIGURE 32INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS105
TABLE 16INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS106
5.16.2BUYING CRITERIA106
FIGURE 33KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS106
TABLE 17KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS106
6COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY107
6.1INTRODUCTION108
TABLE 18COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)108
6.1.1IMPACT OF COVID-19 ON TECHNOLOGY TYPE108
6.2CLINICAL BIOCHEMISTRY109
TABLE 19KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET109
TABLE 20CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 21CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION)110
6.2.1CLINICAL CHEMISTRY ANALYSIS111
TABLE 22KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN MARKET111
TABLE 23CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)112
TABLE 24CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)112
6.2.1.1Reagents, clips, and cartridges113
6.2.1.1.1Increasing pet healthcare expenditure and rising number of screening tests performed to drive market growth113
TABLE 25CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)113
6.2.1.2Analyzers114
6.2.1.2.1Increasing installations of clinical chemistry analyzers to drive market growth114
TABLE 26CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)114
6.2.2GLUCOSE MONITORING115
TABLE 27KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN MARKET115
TABLE 28GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)115
TABLE 29GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
6.2.2.1Blood glucose strips116
6.2.2.1.1Blood glucose strips to account for largest share of market in 2021116
TABLE 30BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)117
6.2.2.2Glucose monitors117
6.2.2.2.1Use of glucose monitors to help in diagnostic and therapeutic decisions117
TABLE 31GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)118
6.2.2.3Urine glucose strips118
6.2.2.3.1Urine glucose strips to measure glucose and ketone concentration in urine118
TABLE 32LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE IN MARKET119
TABLE 33URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
6.2.3BLOOD GAS ELECTROLYTE ANALYSIS119
TABLE 34BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)120
TABLE 35BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)120
6.2.3.1Reagents, clips, and cartridges121
6.2.3.1.1Easy availability of animal species-specific preloaded reagent clips to support market growth121
TABLE 36BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)121
6.2.3.2Blood gas & electrolyte analyzers122
6.2.3.2.1Blood gas and electrolyte analyzers to determine oxygen and carbon dioxide amounts in blood122
TABLE 37BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)122
6.3IMMUNODIAGNOSTICS123
TABLE 38LIST OF KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET123
TABLE 39IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)124
TABLE 40IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
6.3.1LATERAL FLOW ASSAYS125
TABLE 41LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)126
TABLE 42LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
6.3.1.1Rapid tests127
6.3.1.1.1Rising prevalence of infectious diseases to drive lateral flow rapid tests adoption127
TABLE 43LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES127
TABLE 44KEY PLAYERS OFFERING LATERAL TEST KITS127
TABLE 45LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)128
6.3.1.2Strip readers (Lateral flow readers)129
6.3.1.2.1Lateral flow readers to be adopted in in-house testing centers129
TABLE 46LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)130
6.3.2ELISA TESTS130
6.3.2.1Elisa kits to be adopted for viral disease testing in companion animals130
TABLE 47ELISA: ADVANTAGES & DISADVANTAGES131
TABLE 48KEY PLAYERS OFFERING ELISA KITS131
TABLE 49ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
6.3.3ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS132
6.3.3.1Growing number of allergy cases in pets to drive market growth132
TABLE 50ALLERGEN-SPECIFIC IMMUNODIAGNOSTICS TEST KITS AVAILABLE133
TABLE 51ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)133
6.3.4IMMUNOASSAY ANALYZERS134
6.3.4.1Large number of samples can be loaded into immunoassay analyzers to determine immunoassay tests results134
TABLE 52KEY PLAYERS OFFERING IMMUNOASSAY ANALYZERS135
TABLE 53IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)136
6.3.5OTHER IMMUNODIAGNOSTIC PRODUCTS136
TABLE 54KEY PLAYERS OFFERING IMMUNOASSAY REAGENTS & CONSUMABLES137
TABLE 55OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)137
6.4HEMATOLOGY138
TABLE 56KEY HEMATOLOGY PRODUCTS AVAILABLE138
TABLE 57HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)139
TABLE 58HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
6.4.1CARTRIDGES140
6.4.1.1Hematology cartridges to measure hematocrit and hemoglobin levels in animal blood samples140
TABLE 59HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)140
6.4.2ANALYZERS141
6.4.2.1Hematology analyzers to measure blood cell count and coagulation time of blood141
TABLE 60HEMATOLOGY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)141
6.5URINALYSIS142
TABLE 61LIST OF KEY URINALYSIS PRODUCTS AVAILABLE142
TABLE 62URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)143
TABLE 63URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)143
6.5.1CLIPS & CARTRIDGES/PANELS144
6.5.1.1Clips and cartridges/panels to measure multiple electrolytes and metabolites kidney diseases and urinary tract infections detection144
TABLE 64URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)144
6.5.2URINE ANALYZERS145
6.5.2.1Technological advancements to support market growth145
TABLE 65URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)145
6.5.3URINE TEST STRIPS146
6.5.3.1Urine test strips to qualitatively evaluate urine parameters146
TABLE 66URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)146
6.6MOLECULAR DIAGNOSTICS147
TABLE 67MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)147
TABLE 68MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)148
6.6.1POLYMERASE CHAIN REACTION TESTS148
6.6.1.1Increased laboratory usage of PCR in proteomics and genomics to support market growth148
TABLE 69LIST OF POLYMERASE CHAIN REACTION TESTS AVAILABLE149
TABLE 70PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)150
6.6.2MICROARRAYS150
6.6.2.1Growing applications of biochips in infectious diseases identification to propel market growth150
TABLE 71LIST OF MICROARRAYS TESTS AVAILABLE151
TABLE 72MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
6.6.3OTHER MOLECULAR DIAGNOSTIC PRODUCTS152
TABLE 73OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)152
6.7OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES153
TABLE 74OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)153
7COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION154
7.1INTRODUCTION155
TABLE 75COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)155
7.2CLINICAL PATHOLOGY155
7.2.1INCREASING PET HEALTH SCREENING AND DISEASE DIAGNOSIS TO MAKE CLINICAL PATHOLOGY LARGEST APPLICATION SEGMENT155
TABLE 76COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION)156
7.3BACTERIOLOGY156
7.3.1RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH156
TABLE 77COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION)157
7.4VIROLOGY158
7.4.1RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH158
TABLE 78COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)158
7.5PARASITOLOGY159
7.5.1INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT MARKET GROWTH159
TABLE 79COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION)159
7.6OTHER APPLICATIONS160
TABLE 80COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)160
8COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE161
8.1INTRODUCTION162
TABLE 81COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION)162
8.2DOGS163
8.2.1RISING PET DOG POPULATION TO DRIVE MARKET GROWTH163
TABLE 82DOG POPULATION, BY COUNTRY, 2018–2020 (MILLION)163
TABLE 83COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)164
8.3CATS164
8.3.1GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING TO SUPPORT MARKET GROWTH164
TABLE 84CAT POPULATION, BY COUNTRY, 2018-2020 (MILLION)165
TABLE 85COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)166
8.4HORSES166
8.4.1GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH166
TABLE 86COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)168
8.5OTHER COMPANION ANIMALS168
TABLE 87COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER ANIMALS,
BY COUNTRY, 2020–2027 (USD MILLION)169
9COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER170
9.1INTRODUCTION171
TABLE 88COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)171
9.2DIAGNOSTIC LABORATORIES172
9.2.1DIAGNOSTIC LABORATORIES TO RECEIVE LARGE SAMPLE VOLUME FOR DIAGNOSIS172
TABLE 89COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)173
9.3VETERINARY HOSPITALS & CLINICS173
9.3.1VETERINARY HOSPITALS & CLINICS TO BE FIRST POINTS OF CONTACT FOR PET OWNERS173
TABLE 90BASIC ANNUAL EXPENSES FOR CATS AND DOGS IN THE US IN
2021-2022 (USD)174
TABLE 91COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)174
9.4RESEARCH INSTITUTES & UNIVERSITIES175
9.4.1INCREASING INDUSTRY-ACADEMIA COLLABORATIONS TO PROPEL MARKET GROWTH175
TABLE 92COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION)175
9.5HOME-CARE SETTINGS176
9.5.1IMPROVED CARE AND COST CONTROL TO DRIVE POC DIAGNOSTICS ADOPTION IN HOME CARE SETTINGS176
TABLE 93COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME-CARE SETTINGS,
BY COUNTRY, 2020–2027 (USD MILLION)177
10COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION178
10.1INTRODUCTION179
TABLE 94COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION,
2020–2027 (USD MILLION)179
10.2NORTH AMERICA179
FIGURE 34NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT180
TABLE 95NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)181
TABLE 96NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION)181
TABLE 97NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)182
TABLE 98NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)182
TABLE 99NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)182
TABLE 100NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)183
TABLE 101NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)183
TABLE 102NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)183
TABLE 103NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)184
TABLE 104NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)184
TABLE 105NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)184
TABLE 106NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION)185
TABLE 107NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)185
TABLE 108NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY END USER, 2020–2027 (USD MILLION)186
10.2.1US186
10.2.1.1US to dominate companion animal diagnostics market in
North America186
TABLE 109US: PRIVATE CLINICAL PRACTICES FOR COMPANION ANIMAL,
2016 VS. 2020186
FIGURE 35US: EXPENDITURE ON VET VISITS187
TABLE 110US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)187
TABLE 111US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)188
TABLE 112US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)188
TABLE 113US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 114US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)189
TABLE 115US: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)189
TABLE 116US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)189
TABLE 117US: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)190
TABLE 118US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)190
TABLE 119US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)190
TABLE 120US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION)191
TABLE 121US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)191
TABLE 122US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)192
10.2.2CANADA192
10.2.2.1Awareness of pet health to propel market growth192
TABLE 123CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)193
TABLE 124CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)193
TABLE 125CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)194
TABLE 126CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)194
TABLE 127CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)194
TABLE 128CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)195
TABLE 129CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)195
TABLE 130CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)195
TABLE 131CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)196
TABLE 132CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)196
TABLE 133CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)196
TABLE 134CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)197
TABLE 135CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)197
10.3EUROPE198
FIGURE 36EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT199
TABLE 136EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)200
TABLE 137EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)200
TABLE 138EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)201
TABLE 139EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)201
TABLE 140EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)201
TABLE 141EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)202
TABLE 142EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)202
TABLE 143EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)202
TABLE 144EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)203
TABLE 145EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)203
TABLE 146EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)203
TABLE 147EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)204
TABLE 148EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)204
TABLE 149EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)205
10.3.1GERMANY205
10.3.1.1Germany to dominate European companion animal diagnostics market205
TABLE 150GERMANY: PET POPULATION (CATS AND DOGS), 2017 VS. 2020 (MILLION)205
TABLE 151GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)206
TABLE 152GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)206
TABLE 153GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)207
TABLE 154GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)207
TABLE 155GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)207
TABLE 156GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)208
TABLE 157GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)208
TABLE 158GERMANY: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)208
TABLE 159GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)209
TABLE 160GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)209
TABLE 161GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)209
TABLE 162GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)210
TABLE 163GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)210
10.3.2UK210
10.3.2.1Stable increase in pet ownership and preventive measures against animal diseases to drive market growth210
TABLE 164UK: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)211
TABLE 165UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)211
TABLE 166UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)212
TABLE 167UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)212
TABLE 168UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)212
TABLE 169UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)213
TABLE 170UK: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)213
TABLE 171UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)213
TABLE 172UK: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)214
TABLE 173UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)214
TABLE 174UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)214
TABLE 175UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION)215
TABLE 176UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)215
TABLE 177UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)216
10.3.3FRANCE216
10.3.3.1Technological expertise and innovations to attract market players216
TABLE 178FRANCE: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)216
TABLE 179FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)217
TABLE 180FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)217
TABLE 181FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)218
TABLE 182FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)218
TABLE 183FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)218
TABLE 184FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)219
TABLE 185FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)219
TABLE 186FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)219
TABLE 187FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)220
TABLE 188FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)220
TABLE 189FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)220
TABLE 190FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)221
TABLE 191FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)221
10.3.4ITALY221
10.3.4.1Increased pet adoption and better availability of pet products through large-scale outlets to support market growth221
TABLE 192ITALY: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)222
TABLE 193ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)222
TABLE 194ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)222
TABLE 195ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)223
TABLE 196ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)223
TABLE 197ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)223
TABLE 198ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)224
TABLE 199ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)224
TABLE 200ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)224
TABLE 201ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)225
TABLE 202ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)225
TABLE 203ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION)225
TABLE 204ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)226
TABLE 205ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)226
10.3.5SPAIN226
10.3.5.1Rising animal health expenditure and growing number of veterinary facilities to drive market growth226
TABLE 206SPAIN: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)227
TABLE 207SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)227
TABLE 208SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)228
TABLE 209SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)228
TABLE 210SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)228
TABLE 211SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)229
TABLE 212SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)229
TABLE 213SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)229
TABLE 214SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 215SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 216SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)230
TABLE 217SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)231
TABLE 218SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)231
TABLE 219SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION)232
10.3.6BENELUX232
10.3.6.1Increasing pet population in Benelux to drive market growth232
TABLE 220BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)233
TABLE 221BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)233
TABLE 222BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)234
TABLE 223BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION)234
TABLE 224BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)234
TABLE 225BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION)235
TABLE 226BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)235
TABLE 227BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)235
TABLE 228BENELUX: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)236
TABLE 229BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)236
TABLE 230BENELUX

Report Title: Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline